Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22)

Shiro Takata, Kensuke Kojima, Nobuharu Fujii, Kinuyo Kaneda, Chikamasa Yoshida, Daigo Hashimoto, Shoji Asakura, Katsuji Shinagawa, Mitsune Tanimoto

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We report a t(6;8)(q15;q22) in a patient with myelodysplastic syndrome (MDS) with erythroid hypoplasia. The patient was successfully treated with an immunosuppressive treatment with cyclosporin A, while the translocation was repeatedly detected as the sole anomaly with the percentages of positive cells ranging from 5% to 70%. To our knowledge, the t(6;8) has never been described in MDS.

Original languageEnglish
Pages (from-to)167-169
Number of pages3
JournalCancer Genetics and Cytogenetics
Volume140
Issue number2
DOIs
Publication statusPublished - Jan 15 2003

Fingerprint

Myelodysplastic Syndromes
Cyclosporine
Immunosuppressive Agents
Therapeutics
N(6)-(N-threonylcarbonyl)adenosine

ASJC Scopus subject areas

  • Cancer Research
  • Genetics
  • Molecular Biology

Cite this

Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). / Takata, Shiro; Kojima, Kensuke; Fujii, Nobuharu; Kaneda, Kinuyo; Yoshida, Chikamasa; Hashimoto, Daigo; Asakura, Shoji; Shinagawa, Katsuji; Tanimoto, Mitsune.

In: Cancer Genetics and Cytogenetics, Vol. 140, No. 2, 15.01.2003, p. 167-169.

Research output: Contribution to journalArticle

Takata, Shiro ; Kojima, Kensuke ; Fujii, Nobuharu ; Kaneda, Kinuyo ; Yoshida, Chikamasa ; Hashimoto, Daigo ; Asakura, Shoji ; Shinagawa, Katsuji ; Tanimoto, Mitsune. / Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22). In: Cancer Genetics and Cytogenetics. 2003 ; Vol. 140, No. 2. pp. 167-169.
@article{99fe42c915bb4f22a42d167dc6763907,
title = "Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22)",
abstract = "We report a t(6;8)(q15;q22) in a patient with myelodysplastic syndrome (MDS) with erythroid hypoplasia. The patient was successfully treated with an immunosuppressive treatment with cyclosporin A, while the translocation was repeatedly detected as the sole anomaly with the percentages of positive cells ranging from 5{\%} to 70{\%}. To our knowledge, the t(6;8) has never been described in MDS.",
author = "Shiro Takata and Kensuke Kojima and Nobuharu Fujii and Kinuyo Kaneda and Chikamasa Yoshida and Daigo Hashimoto and Shoji Asakura and Katsuji Shinagawa and Mitsune Tanimoto",
year = "2003",
month = "1",
day = "15",
doi = "10.1016/S0165-4608(02)00655-6",
language = "English",
volume = "140",
pages = "167--169",
journal = "Cancer Genetics and Cytogenetics",
issn = "0165-4608",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Successful treatment with cyclosporin A of myelodysplastic syndrome with erythroid hypoplasia associated with t(6;8)(q15;q22)

AU - Takata, Shiro

AU - Kojima, Kensuke

AU - Fujii, Nobuharu

AU - Kaneda, Kinuyo

AU - Yoshida, Chikamasa

AU - Hashimoto, Daigo

AU - Asakura, Shoji

AU - Shinagawa, Katsuji

AU - Tanimoto, Mitsune

PY - 2003/1/15

Y1 - 2003/1/15

N2 - We report a t(6;8)(q15;q22) in a patient with myelodysplastic syndrome (MDS) with erythroid hypoplasia. The patient was successfully treated with an immunosuppressive treatment with cyclosporin A, while the translocation was repeatedly detected as the sole anomaly with the percentages of positive cells ranging from 5% to 70%. To our knowledge, the t(6;8) has never been described in MDS.

AB - We report a t(6;8)(q15;q22) in a patient with myelodysplastic syndrome (MDS) with erythroid hypoplasia. The patient was successfully treated with an immunosuppressive treatment with cyclosporin A, while the translocation was repeatedly detected as the sole anomaly with the percentages of positive cells ranging from 5% to 70%. To our knowledge, the t(6;8) has never been described in MDS.

UR - http://www.scopus.com/inward/record.url?scp=0037438882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037438882&partnerID=8YFLogxK

U2 - 10.1016/S0165-4608(02)00655-6

DO - 10.1016/S0165-4608(02)00655-6

M3 - Article

VL - 140

SP - 167

EP - 169

JO - Cancer Genetics and Cytogenetics

JF - Cancer Genetics and Cytogenetics

SN - 0165-4608

IS - 2

ER -